Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
168(c) 168(c) 160(c) 159.5(c) 154(c) Last
85 778 209 309 123 526 78 767 44 782 Volume
-1.75% 0.00% -4.76% -0.31% -3.45% Change
More quotes
Financials (USD)
Sales 2018 3,30 M
EBIT 2018 -131 M
Net income 2018 -68,3 M
Finance 2018 95,5 M
Yield 2018 -
Sales 2019 1,37 M
EBIT 2019 -151 M
Net income 2019 -64,1 M
Finance 2019 50,5 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 157x
EV / Sales2019 411x
Capitalization 613 M
More Financials
Company
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune.It operates through the following segments: Growth Stage Businesses; Project Phase Businesses; and... 
Sector
Biotechnology & Medical Research
Calendar
05/18 | 04:00pmShareholder meeting
More about the company
Surperformance© ratings of Puretech Health PLC
Trading Rating : - Investor Rating :
More Ratings
Latest news on PURETECH HEALTH PLC
04/19PURETECH HEALTH : Sonde Health Announces U.S. and Australian Patent Issuances Br..
AQ
04/17PURETECH HEALTH : 2017 Loss Narrows As Clinical Trial Progress Continues
AQ
04/12PURETECH HEALTH : Alivio Technology for Treating Inflammatory Diseases via Targe..
AQ
04/11PURETECH HEALTH : affiliates expand digital medicine IP portfolios with key pate..
AQ
04/10PURETECH HEALTH : Akili Digital Medicine Technology Platform Granted Multiple Pa..
BU
04/10PURETECH HEALTH : Sonde Health Announces U.S. and Australian Patent Issuances Br..
BU
04/09PURETECH HEALTH : Commense Appoints Edward J. “Tad” Stewart as Presi..
BU
04/03PURETECH HEALTH : Alivio Technology for Treating Inflammatory Diseases via Targe..
BU
03/01GELESIS : Raises $30 Million to Prepare for Potential Launch of Lead Product
BU
01/29RESTORBIO : BioCentury - resTORbio raises $85M IPO
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
04/20Ben Shapiro Jokes: Obama’s ‘Glowing Profile’ of Parkland Students in Time 100..
1
04/19Ben Shapiro: If You Don't Agree With Me, You're a Racist Who Likes Death Thre..
4
04/17Ben Shapiro on Trump Syria Strike: What Do We Want America to Do in the World..
3
04/17Oh dear, am I going to have to figure out how to mute Ben Shapiro references? 
04/16After a false early report that the Quebec City mosque massacre was co-perpet..
2383
More tweets
Qtime:82
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 3,63 $
Spread / Average Target 68%
EPS Revisions
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Eric Elenko Chief-Research & Strategy
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC2.67%613
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.09%14 493
NEKTAR THERAPEUTICS44.36%13 873